The primary endpoint was prostate tumor markers of cancer development and progression determined by tissue immunostaining of proliferation ( Ki67 ) , apoptosis ( Bcl-2 , Bax , Tunel ) , inflammation ( nuclear and cytoplasmic nuclear factor kappa B [ NFB ] ) and oxidation ( 8-hydroxydeoxy-guanosine [ 8OHdG ] ) .